0 Commentarii
0 Distribuiri
246 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Biosimilars Market: Demand, Innovation, and Regulatory LandscapeThe biosimilars market is rapidly transforming the global pharmaceutical landscape by offering cost-effective alternatives to biologic drugs. Biosimilars are highly similar versions of approved biologics, designed to match their safety, efficacy, and quality while improving accessibility and reducing healthcare costs. As patents for major biologics expire, biosimilars are gaining significant...0 Commentarii 0 Distribuiri 677 Views 0 previzualizare
-
US Biosimilars Market: Is the "Rebate Wall" Still the Biggest Barrier to Patient Access in 2026?The global pharmaceutical landscape is entering a transformative era as the patents for several blockbuster biologics expire, paving the way for more affordable alternatives. As of 2026, the Biosimilars Market is reaching new heights, driven by an urgent need to contain healthcare costs as chronic disease rates climb. These follow-on biologics, which are highly similar to their reference...0 Commentarii 0 Distribuiri 488 Views 0 previzualizare
-
Cancer Drugs Market Thrives Amid AI Integration, Advanced Immunotherapies, and Global Access InitiativesUnited States of America – The Insight Partners has released a comprehensive report titled “Cancer Drugs Market Share, Size, Trends, and Forecast by 2031, The cancer drugs market is at a pivotal juncture—patients, care teams, and researchers are witnessing a revolution in how cancer is understood, treated, and managed. Today’s cancer drugs landscape is shaped by...0 Commentarii 0 Distribuiri 67K Views 0 previzualizare
-
Future Outlook: The Next Generation of Biosimilars and the Expansion into Rare DiseasesAs the first generation of biosimilars becomes well-established, the industry is looking toward more complex molecules. The next wave will likely include biosimilars for orphan drugs, which are used to treat rare diseases. While the patient population for these drugs is smaller, the high cost per patient makes biosimilar development commercially viable. This expansion represents a new frontier...0 Commentarii 0 Distribuiri 541 Views 0 previzualizare
-
Global Biopharmaceutical and Bio-CDMO Market Growing at 14.2% CAGR Through 2032According to a new report from Intel Market Research, the global Biopharmaceutical and Bio-CDMO market was valued at USD 25.71 billion in 2024 and is projected to grow from USD 28.95 billion in 2025 to USD 63.88 billion by 2032, exhibiting a robust CAGR of 14.2% during the forecast period (2025–2032). This growth is driven by increasing demand for biologics and biosimilars due to their...0 Commentarii 0 Distribuiri 104 Views 0 previzualizare
-
Navigating Travel and Storage with Biosimilars in Early 2026For patients who love to travel, managing a refrigerated biological medicine used to be a major logistical challenge, but in early 2026, the "Travel-Ready" features of biosimilars are changing the game. Many 2026 biosimilar manufacturers now provide complimentary "Smart Travel Kits" that include compact, battery-powered cooling cases that can maintain the perfect temperature for up to 48 hours....0 Commentarii 0 Distribuiri 578 Views 0 previzualizare
-
The UK and South America: A Tale of Two Different Insulin Biosimilars MarketsThe UK has always had a "common sense" approach to health, and the UK Insulin Biosimilars Market reflects that. In 2026, the NHS has fully embraced biosimilars to save billions of pounds. What’s cool is that they’re reinvesting those savings into newer tech, like continuous glucose monitors. It’s a win-win: the system saves money, and the patients get access to even...0 Commentarii 0 Distribuiri 716 Views 0 previzualizare